ACM
QNRX

Altium Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Altium Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,064
Closed -$184K – 56
2024
Q4 		$184K Buy
+8,064
New +$185K 0.05% 65
2024
Q3 		– Sell
-2,946
Closed -$59.8K – 93
2024
Q2 		$59.8K Buy
2,946
+1,053
+56% +$26.8K 0.02% 51
2024
Q1 		$62.9K Buy
+1,893
New +$187K 0.02% 54

Other funds holding QNRX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Altium Capital Management's QNRX Position: Q1 2025 in Review

Altium Capital Management sold out of Quoin Pharmaceuticals (QNRX) in Q1 2025, closing a stake of 8,064 shares — an estimated $184K sold.

Altium Capital Management first reported a position in QNRX in Q1 2024 and held it in 3 quarters. The position peaked at $184K in Q4 2024. 9 funds tracked by Wall St. Rank hold QNRX as of Q1 2025.

  • Altium Capital Management reported no remaining Quoin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Altium Capital Management sold 8,064 Quoin Pharmaceuticals shares in Q1 2025, an estimated $184K.
  • Altium Capital Management first reported a position in Quoin Pharmaceuticals in Q1 2024 and held it in 3 quarters.
  • Altium Capital Management's Quoin Pharmaceuticals position peaked at $184K in Q4 2024.
  • 9 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2025.

Based on Altium Capital Management's 13F filing for Q1 2025, filed 9 May 2025.